These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 34224329)

  • 41. Deferasirox does not induce QT/QTc-prolongation in healthy subjects.
    Sechaud R; Dumortier T; Balez S
    Int J Clin Pharmacol Ther; 2009 May; 47(5):321-7. PubMed ID: 19473594
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identifying the translational gap in the evaluation of drug-induced QTc interval prolongation.
    Chain AS; Dubois VF; Danhof M; Sturkenboom MC; Della Pasqua O;
    Br J Clin Pharmacol; 2013 Nov; 76(5):708-24. PubMed ID: 23351036
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Drugs, QT interval prolongation and ICH E14: the need to get it right.
    Shah RR
    Drug Saf; 2005; 28(2):115-25. PubMed ID: 15691222
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Factors affecting the degree of QT prolongation with drug challenge in a large cohort of normal volunteers.
    Kannankeril PJ; Norris KJ; Carter S; Roden DM
    Heart Rhythm; 2011 Oct; 8(10):1530-4. PubMed ID: 21420510
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enabling robust assessment of QTc prolongation in early phase clinical trials.
    Mehrotra DV; Fan L; Liu F; Tsai K
    Pharm Stat; 2017 May; 16(3):218-227. PubMed ID: 28374497
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Olaparib does not cause clinically relevant QT/QTc interval prolongation in patients with advanced solid tumours: results from two phase I studies.
    Swaisland H; Plummer R; So K; Garnett S; Bannister W; Fabre MA; Dota C; Fielding A
    Cancer Chemother Pharmacol; 2016 Oct; 78(4):775-84. PubMed ID: 27553432
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PKPD and cardiac single cell modeling of a DDI study with a CYP3A4 substrate and itraconazole to quantify the effects on QT interval duration.
    Jaminion F; Bentley D; Wang K; Wandel C; Derks M; Diack C
    J Pharmacokinet Pharmacodyn; 2020 Oct; 47(5):447-459. PubMed ID: 32572738
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Do Studies Evaluating QT/QTc Interval Prolongation with Dietary Supplements Meet FDA Standards: A Systematic Review.
    Nguyen TA; Kurian A; Leong J; Patel UM; Shah SA
    J Diet Suppl; 2017 Jul; 14(4):467-477. PubMed ID: 27937000
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Concentration-QTc analysis with two or more correlated baselines.
    Orihashi Y; Kumagai Y
    J Pharmacokinet Pharmacodyn; 2021 Oct; 48(5):615-622. PubMed ID: 33977390
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of nalmefene 20 and 80 mg on the corrected QT interval and T-wave morphology: a randomized, double-blind, parallel-group, placebo- and moxifloxacin-controlled, single-centre study.
    Matz J; Graff C; Vainio PJ; Kallio A; Højer AM; Struijk JJ; Kanters JK; Andersen MP; Toft E
    Clin Drug Investig; 2011 Nov; 31(11):799-811. PubMed ID: 21967071
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetic-pharmacodynamic modelling of the effect of Moxifloxacin on QTc prolongation in telemetered cynomolgus monkeys.
    Watson KJ; Gorczyca WP; Umland J; Zhang Y; Chen X; Sun SZ; Fermini B; Holbrook M; Van Der Graaf PH
    J Pharmacol Toxicol Methods; 2011; 63(3):304-13. PubMed ID: 21419854
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessment of the effect of a single oral dose of telithromycin on sotalol-induced qt interval prolongation in healthy women.
    Démolis JL; Strabach S; Vacheron F; Funck-Brentano C
    Br J Clin Pharmacol; 2005 Aug; 60(2):120-7. PubMed ID: 16042664
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessment of drug-induced QT interval prolongation in conscious rabbits.
    Kijtawornrat A; Ozkanlar Y; Keene BW; Roche BM; Hamlin DM; Hamlin RL
    J Pharmacol Toxicol Methods; 2006; 53(2):168-73. PubMed ID: 16290300
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of inotuzumab ozogamicin on the QT interval in patients with haematologic malignancies using QTc-concentration modelling.
    Hibma JE; Kantarjian HM; DeAngelo DJ; Boni JP
    Br J Clin Pharmacol; 2019 Mar; 85(3):590-600. PubMed ID: 30536405
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Drug induced shortening of the QT/QTc interval: an emerging safety issue warranting further modelling and evaluation in drug research and development?
    Holbrook M; Malik M; Shah RR; Valentin JP
    J Pharmacol Toxicol Methods; 2009; 59(1):21-8. PubMed ID: 18834945
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Statistical assessment of QT/QTc prolongation based on maximum of correlated normal random variables.
    Cheng B; Chow SC; Burt D; Cosmatos D
    J Biopharm Stat; 2008; 18(3):494-501. PubMed ID: 18470758
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Abnormalities of rate-corrected QT intervals in Parkinson's disease-a comparison with multiple system atrophy and progressive supranuclear palsy.
    Deguchi K; Sasaki I; Tsukaguchi M; Kamoda M; Touge T; Takeuchi H; Kuriyama S
    J Neurol Sci; 2002 Jul; 199(1-2):31-7. PubMed ID: 12084439
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sources of QTc variability: Implications for effective ECG monitoring in clinical practice.
    Hnatkova K; Malik M
    Ann Noninvasive Electrocardiol; 2020 Mar; 25(2):e12730. PubMed ID: 31760674
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relationship between serum bepridil concentration and corrected QT interval.
    Matsui K; Mukai Y; Sakakura K; Wada K; Nakamura T; Kawabata A; Terakawa N; Hayakawa N; Kusano K; Hosomi K; Yokoyama S; Takada M
    Int J Clin Pharmacol Ther; 2021 Jan; 59(1):63-70. PubMed ID: 33026317
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Statistical issues including design and sample size calculation in thorough QT/QTc studies.
    Zhang J; Machado SG
    J Biopharm Stat; 2008; 18(3):451-67. PubMed ID: 18470755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.